Clinical characteristics and dose-volume histogram parameters associated with the development of pleural effusions in non-small cell lung cancer patients treated with chemoradiation therapy

References

• Curran WJ Jr., Choy H. Optimizing chemoradiation in locally advanced non-small-cell lung cancer. Oncology (Williston Park, N.Y.) 2001;15:43–5.
   PubMed Web of Science ®Google Scholar
• Down JD, Easton DF, Steel GG. Repair in the mouse lung during low dose-rate irradiation. Radiother Oncol 1986;6:29–42.
   PubMed Web of Science ®Google Scholar
• Shirai K, Tamaki Y, Kitamoto Y, Murata K, Satoh Y, Higuchi K, et al. Dose-volume histogram parameters and clinical factors associated with pleural effusion after chemoradiotherapy in esophageal cancer patients. Int J Radiat Oncol Biol Phys 2011;80:1002–7.
   PubMed Web of Science ®Google Scholar
• Morota M, Gomi K, Kozuka T, Chin K, Matsuura M, Oguchi M, et al. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 2009;75:122–8.
   PubMed Web of Science ®Google Scholar
• Jiang WG. In-vitro models of cancer invasion and metastasis: recent developments. Eur J Surg Oncol 1994;20:493–9.
   PubMedGoogle Scholar
• Hietala SO, Hahn P. Pulmonary radiation reaction in the treatment of carcinoma of the breast. Radiography 1976;42:225–30.
   PubMedGoogle Scholar
• Whitcomb ME, Schwarz MI. Pleural effusion complicating intensive mediastinal radiation therapy. Am Rev Respir Dis 1971;103:100–7.
   PubMed Web of Science ®Google Scholar
• Kumar R, Patel G, Kichenadasse G, Sukumaran S, Roy A, Koczwara B, et al. Delayed onset of benign pleural effusion following concurrent chemoradiotherapy for inoperable non-small-cell lung cancer. Intern Med J 2015;45:218–21.
   PubMed Web of Science ®Google Scholar
• Jabbour SK, Daroui P, Moore D, Licitra E, Gabel M, Aisner J. A novel paradigm in the treatment of oligometastatic non-small cell lung cancer. J Thorac Dis 2011;3:4–9.
   PubMedGoogle Scholar
• Lababede O, Meziane MA, Rice TW. TNM staging of lung cancer: a quick reference chart. Chest 1999;115:233–5.
   PubMed Web of Science ®Google Scholar
• Kong FM, Ritter T, Quint DJ, Senan S, Gaspar LE, Komaki RU, et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys 2011;81:1442–57.
   PubMed Web of Science ®Google Scholar
• Park S, Urm S, Cho H. Analysis of biologically equivalent dose of stereotactic body radiotherapy for primary and metastatic lung tumors. Cancer Res Treat 2014;46:403–10.
   PubMedGoogle Scholar
• Glazer HS, Duncan-Meyer J, Aronberg DJ, Moran JF, Levitt RG, Sagel SS. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation. Radiology 1985;157:191–4.
   PubMed Web of Science ®Google Scholar
• Wei L, Lin D,LW. Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal Distributions. J Am Stat Assoc 1989;84:1065–73.
   Web of Science ®Google Scholar
• McGrath EE, Anderson PB. Diagnosis of pleural effusion: a systematic approach. Am J Crit Care 2011;20:119–27; quiz 28.
   PubMed Web of Science ®Google Scholar
• Huang EX, Hope AJ, Lindsay PE, Trovo M, El Naqa I, Deasy JO, et al. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 2011;50:51–60.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Muren LP. Advancing our quantitative understanding of radiotherapy normal tissue morbidity. Acta Oncol 2014;53:577–9.
   PubMed Web of Science ®Google Scholar
• Tucker SL, Liao Z, Dinh J, Bian SX, Mohan R, Martel MK, et al. Is there an impact of heart exposure on the incidence of radiation pneumonitis? Analysis of data from a large clinical cohort. Acta Oncol 2014;53:590–6.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Kapoor JR. Radiation induced heart disease: systemic disorders in heart disease. Heart 2009;95:252–8.
   PubMed Web of Science ®Google Scholar
• Hatakenaka M, Yonezawa M, Nonoshita T, Nakamura K, Yabuuchi H, Shioyama Y, et al. Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer: magnetic resonance evaluation. Int J Radiat Oncol Biol Phys 2012;83:e67–73.
   PubMed Web of Science ®Google Scholar
• Gomez DR, Yusuf SW, Munsell MF, Welsh JW, Liao Z, Lin SH, et al. Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure. J Thorac Oncol 2014;9:1554–60.
   PubMed Web of Science ®Google Scholar
• Nalbantov G, Kietselaer B, Vandecasteele K, Oberije C, Berbee M, Troost E, et al. Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients. Radiother Oncol 2013;109:100–6.
   PubMed Web of Science ®Google Scholar
• Kwint M, Conijn S, Schaake E, Knegjens J, Rossi M, Remeijer P, et al. Intra thoracic anatomical changes in lung cancer patients during the course of radiotherapy. Radiother Oncol 2014;113:392–7.
   PubMed Web of Science ®Google Scholar
• Lim MH, Garrettc J, Mowlem L, Yap E. Diagnosing malignant pleural effusions: how do we compare? N Z Med J 2013;126:42–8.
   PubMedGoogle Scholar
• Ong KC, Indumathi V, Poh WT, Ong YY. The diagnostic yield of pleural fluid cytology in malignant pleural effusions. Singapore Med J 2000;41:19–23.
   PubMedGoogle Scholar